| For: | Leite NC, Villela-Nogueira CA, Cardoso CRL, Salles GF. Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment. World J Gastroenterol 2014; 20(26): 8377-8392 [PMID: 25024596 DOI: 10.3748/wjg.v20.i26.8377] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8377.htm |
| Number | Citing Articles |
| 1 |
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli-Pekka Koivurova, Juha Perkiömäki, Heikki Huikuri, Olavi Ukkola. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. Metabolism 2017; 66 doi: 10.1016/j.metabol.2016.06.009
|
| 2 |
Satoshi Sato, Chikara Iino, Takafumi Sasada, Keisuke Furusawa, Kenta Yoshida, Kaori Sawada, Tatsuya Mikami, Shigeyuki Nakaji, Hirotake Sakuraba, Shinsaku Fukuda. Effect of Oral and Gut Microbiota, Dietary Intake, and Genetic Polymorphisms on Older Adults with Metabolic Dysfunction Associated Fatty Liver Disease. Sage Open Aging 2026; 12 doi: 10.1177/30495334261458922
|
| 3 |
Marieh Salavatizadeh, Samira Soltanieh, Amirhossein Ataei Kachouei, Zahra Abdollahi Fallahi, Hamed Kord-Varkaneh, Hossein Poustchi, Asieh Mansour, Mohammad E. Khamseh, Fariba Alaei-Shahmiri, Heitor O. Santos, Azita Hekmatdoost. Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1228072
|
| 4 |
Nada Vujić-Jović, Damir Hodžić, Lena Jović, Jelena Gudelj-Rakić, Snežana Dejanović, Kristina Bulatović, Branko Jakovljević, Miloš Maksimović. Diabetes type 2 risk assessment in persons undergoing preventative examinations. Glasnik javnog zdravlja 2025; 99(2) doi: 10.5937/serbjph2502084V
|
| 5 |
V. M. Durleshter, S. A. Gabriel’, N. V. Korochanskaya, A. Yu. Buhtoyarov, P. V. Markov, D. S. Murashko, O. A. Oganesyan, L. G. Izmailova, M. A. Basenko, Yu. V. Horon'ko. Transjugular intrahepatic portosystemic stent-shunt as minimally invasive method of portal hypertension correction in multi-disciplinary clinic. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(4) doi: 10.16931/1995-5464.2020495-106
|
| 6 |
Xiao Zhai, Xiao Chen, Jiancan Lu, Yaping Zhang, Xuejun Sun, Qin Huang, Qijin Wang. Hydrogen-rich saline improves non-alcoholic fatty liver disease by alleviating oxidative stress and activating hepatic PPARα and PPARγ. Molecular Medicine Reports 2017; 15(3) doi: 10.3892/mmr.2017.6120
|
| 7 |
Katsutoshi Maeta, Yu Nishiyama, Kazutoshi Fujibayashi, Toshiaki Gunji, Noriko Sasabe, Kimiko Iijima, Toshio Naito. Prediction of Glucose Metabolism Disorder Risk Using a Machine Learning Algorithm: Pilot Study. JMIR Diabetes 2018; 3(4) doi: 10.2196/10212
|
| 8 |
Yuqing Zhu, Yani Ke, Yijie Hu, Kaihan Wu, Shan Liu, Jie Hu. Association of circulating vaspin levels and patients with metabolic-associated fatty liver disease: a systematic review and meta-analysis. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01658-2
|
| 9 |
Xiaoxiao Liu, Zesheng Peng, Shifeng Ma, Fei Liu, Mingyue Liu, Xiaowen Li, Rongxiu Zheng. Value of elevated 1-hour post-load plasma glucose level in identifying risk of MAFLD in non-diabetic obese children and adolescents. BMC Pediatrics 2025; 25(1) doi: 10.1186/s12887-025-05943-8
|
| 10 |
Ankita Dua, Rashmi Kumari, Mona Singh, Roushan Kumar, Sunila Pradeep, Akinyemi I. Ojesina, Roshan Kumar. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1618275
|
| 11 |
Ji-Youn Kim, Yong-Moon Park, Gyu-Na Lee, Hyun Chul Song, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko, Houkai Li. Association between toothbrushing and non-alcoholic fatty liver disease. PLOS ONE 2021; 16(5) doi: 10.1371/journal.pone.0243686
|
| 12 |
Xiaoyu Wang, Yong Han, Yufei Liu, Haofei Hu. Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02500-w
|
| 13 |
Lina Albitar. Evaluation of diagnostic parameters in detecting prediabetes in a cohort of Syrian healthcare providers and staff: correlations with risk factors. Heliyon 2022; 8(12) doi: 10.1016/j.heliyon.2022.e12195
|
| 14 |
Hind Zafrah, Saif A. Alqahtani, Fahaid Al-Hashem, Bahjat Al-Ani, Nourah M. Alzamil. Metformin is associated with the suppression of the TNF-α/iNOS/TIMP-1 axis-mediated liver injury and fibrosis secondary to diabetes. Tissue and Cell 2026; 101 doi: 10.1016/j.tice.2026.103425
|
| 15 |
Oana Irina Gavril, Lidia Iuliana Arhire, Ovidiu Mitu, Radu Sebastian Gavril, Alexandra Mastaleru, Madalina Ioana Zota, Maria-Magdalena Leon-Constantin, Teodor Vasilcu, Laura Mihalache, Florin Mitu. Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. Internal Medicine 2019; 16(1) doi: 10.2478/inmed-2019-0052
|
| 16 |
Hyun Ho SUNG, Ho-Keun CHOI. Relationship between the Serum De Ritis Ratio and Diabetes Tests in Korean Adults Who Underwent Health Screening at a General Hospital in Gyeonggi-do. Korean Journal of Clinical Laboratory Science 2023; 55(1) doi: 10.15324/kjcls.2023.55.1.9
|
| 17 |
Eleni Asprouli, Ioanna Panagiota Kalafati, Aikaterini Sakellari, Sotirios Karavoltsos, John Vlachogiannakos, Konstantinos Revenas, Alexander Kokkinos, Manos Dassenakis, George V. Dedoussis, Nick Kalogeropoulos. Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease. Biological Trace Element Research 2019; 188(2) doi: 10.1007/s12011-018-1432-9
|
| 18 |
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19) doi: 10.3390/ijerph16193570
|
| 19 |
Petar Avramovski, Maja Avramovska, Zorica Nikleski, Biljana Ilkovska, Kosta Sotiroski, Emilija Sikole. The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease. Indian Journal of Gastroenterology 2020; 39(1) doi: 10.1007/s12664-019-01009-7
|
| 20 |
Nobuyuki Toshikuni, Mutsumi Tsuchishima, Atsushi Fukumura, Tomiyasu Arisawa, Mikihiro Tsutsumi. Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis. Gastroenterology Research and Practice 2017; 2017 doi: 10.1155/2017/9127847
|
| 21 |
Juergen Sandow. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. 2020; doi: 10.1007/978-3-319-68864-0_33
|
| 22 |
Jiang Deng, Zhiyi Han, Hailing Tang, Cong Yao, Xiaoling Li, Jingyuan Xu, Mimi Zhou, Xin Xing, Fangxiong Wu, Jianning Li, Xiaolan Lu, Haitao Shi. Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02615-0
|
| 23 |
Yan Zhao, Wenli Zhao, Huaien Bu, Maeda Toshiyoshi, Ye Zhao. Liraglutide on type 2 diabetes mellitus with nonalcoholic fatty liver disease: A systematic review and meta-analysis of 16 RCTs. Medicine 2023; 102(6) doi: 10.1097/MD.0000000000032892
|
| 24 |
Clelia Asero, Annalisa Giandalia, Irene Cacciola, Carmela Morace, Giuseppe Lorello, Amalia Rita Caspanello, Angela Alibrandi, Giovanni Squadrito, Giuseppina T. Russo. High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2023; 12(8) doi: 10.3390/jcm12082858
|
| 25 |
Philip N. Newsome, Melissa Palmer, Bradley Freilich, Muhammad Y. Sheikh, Aasim Sheikh, Harry Sarles, Robert Herring, Parvez Mantry, Zeid Kayali, Tarek Hassanein, Hak-Myung Lee, Guruprasad P. Aithal. Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study. Journal of Hepatology 2020; 73(2) doi: 10.1016/j.jhep.2020.03.024
|
| 26 |
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
|
| 27 |
Mehmet Sayiner, Aaron Koenig, Linda Henry, Zobair M. Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clinics in Liver Disease 2016; 20(2) doi: 10.1016/j.cld.2015.10.001
|
| 28 |
Suresh Bendwal, Kavita Bendwal, Dhawale R.G. PREVALENCE OF NAFLD IN TYPE 2 DIABETES MELLITUS AND ITS CORRELATION WITH HBA1C LEVEL. Journal of Evidence Based Medicine and Healthcare 2017; 4(31) doi: 10.18410/jebmh/2017/360
|
| 29 |
Yueying Qi, Lirong Fan, Decong Ran, Jieda Xu, Yuansong Wang, Jin Wu, Zhongyong Zhang, Muhammad Wasim Khan. Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. Journal of Oncology 2021; 2021 doi: 10.1155/2021/7764817
|
| 30 |
Signe Foghsgaard, Camilla Andreasen, Louise Vedtofte, Emilie S. Andersen, Emilie Bahne, Charlotte Strandberg, Thora Buhl, Jens J. Holst, Jens A. Svare, Tine D. Clausen, Elisabeth R. Mathiesen, Peter Damm, Lise L. Gluud, Filip K. Knop, Tina Vilsbøll. Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference. Diabetes Care 2017; 40(1) doi: 10.2337/dc16-1017
|
| 31 |
Jangwon Choi, Hyun Joe, Jung-Eun Oh, Yong-Jin Cho, Hwang-Sik Shin, Nam Hun Heo, Gulali Aktas. The correlation between NAFLD and serum uric acid to serum creatinine ratio. PLOS ONE 2023; 18(7) doi: 10.1371/journal.pone.0288666
|
| 32 |
Yitian Dong, Jiayuan Ye, Hui Li, Weiliang Kong, Guoqing Qian, Yilian Xie. U-shaped association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with NAFLD: results from the NHANES database prospective cohort study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04082-9
|
| 33 |
Natália Coelho Lavrado, Gil Fernando Salles, Claudia Regina Lopes Cardoso, Paulo Henrique Condeixa de França, Maria Fernanda Di Guimarães Gonçalves Melo, Nathalie Carvalho Leite, Cristiane Alves Villela‐Nogueira. Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus. Liver International 2024; 44(4) doi: 10.1111/liv.15845
|
| 34 |
Isabel M.A. Brüggenwirth, Natasha H. Dolgin, Robert J. Porte, Adel Bozorgzadeh, Paulo N.A. Martins. Donor Diabetes and Prolonged Cold Ischemia Time Synergistically Increase the Risk of Graft Failure After Liver Transplantation. Transplantation Direct 2017; 3(7) doi: 10.1097/TXD.0000000000000692
|
| 35 |
Karen D. Corbin, Anastassios G. Pittas, Cyrus Desouza, Kristine K. Grdinovac, Karl-Heinz Herzig, Sangeeta R. Kashyap, Sun H. Kim, Jason Nelson, Neda Rasouli, Ellen M. Vickery, William C. Knowler, Richard E. Pratley. Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study. Journal of Diabetes and its Complications 2023; 37(6) doi: 10.1016/j.jdiacomp.2023.108475
|
| 36 |
Yvonne Alt, Jörn M. Schattenberg. Derzeit bleiben als Gegenmittel nur Aufmerksamkeit und Lebensstilmodifikation. Info Diabetologie 2015; 9(1) doi: 10.1007/s15034-014-0624-4
|
| 37 |
Eider Talavera-Urquijo, Sarai Rodríguez-Navarro, Marc Beisani, Maria Teresa Salcedo-Allende, Aisha Chakkur, Marc Arús-Avilés, Manel Cremades, Salvador Augustin, María Martell, José M. Balibrea. Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease. Obesity Surgery 2018; 28(1) doi: 10.1007/s11695-017-2805-4
|
| 38 |
Ji-Youn Kim, Gyu-Na Lee, Hyun Chul Song, Yong-Moon Park, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko. Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination Survey. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60797-7
|
| 39 |
Sultan Alfawaz, Abdulhadi Burzangi , Ahmed Esmat. Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review. Cureus 2024; doi: 10.7759/cureus.67080
|
| 40 |
Babalola Ishmael Afolabi, Bolanle Olubunmi Ibitoye, Rosemary Temidayo Ikem, Adeleye Dorcas Omisore, Bukunmi Michael Idowu, David Olubukunmi Soyoye. The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients. Journal of the National Medical Association 2018; 110(3) doi: 10.1016/j.jnma.2017.06.001
|
| 41 |
Chung‐Hao Li, Yu‐Tsung Chou, Wei‐Chen Shen, Feng‐Hwa Lu, Yi‐Ching Yang, Jin‐Shang Wu, Chih‐Jen Chang. Increased risks of different grades of non‐alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7–6.4% in a Chinese population. Journal of Diabetes Investigation 2020; 11(5) doi: 10.1111/jdi.13268
|
| 42 |
Ashay Shah, Arifa Bakerywala, Riya N. Brahmbhatt, Heena Shaikh, Nidhi Shashikant Bhutak, Renu Singh. The Occurrence of Non-Alcoholic Fatty Liver Disease among Individuals with Diabetes Mellitus: A Comparative Study. Journal of Pharmacy and Bioallied Sciences 2025; 17(Suppl 1) doi: 10.4103/jpbs.jpbs_2016_24
|
| 43 |
Jingsi Cao, Tingting Bao, Jingxian Cao, Xuechun Fan, Yanyan Wang, Jing Yu, Ying Wang, RuiXue Deng, Jingjing Shi, Changlong Shen, Qingwei Li, Jia Mi. Metabolic dysfunction-associated fatty liver in type 2 diabetes mellitus patient: can a systematic review of and meta-analysis of commonly used TCM-preparation shed light on their efficacy?. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1578371
|
| 44 |
Kai Wang, Yiran Wei, Ruijuan Xu, Yiyi Li, Cungui Mao. Sphingolipid Metabolism and Metabolic Disease. Advances in Experimental Medicine and Biology 2022; 1372 doi: 10.1007/978-981-19-0394-6_11
|
| 45 |
Abbas Ali Sangouni, Shirin Hassani Zadeh, Hassan Mozaffari-Khosravi, Mahdieh Hosseinzadeh. Effect of Mediterranean diet on liver enzymes: a systematic review and meta-analysis of randomised controlled trials. British Journal of Nutrition 2022; 128(7) doi: 10.1017/S0007114521002270
|
| 46 |
Catherine Behzad, Zainab Shateri, Nima Motamed, Mansooreh Maadi, Hossein Ajdarkosh, Elham Sobhrakhshankhah, Farhad Zamani, Azam Doustmohammadian, Mehran Nouri. Association of cardiometabolic index with non-alcoholic fatty liver disease among Iranian adults of the amol cohort study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04271-6
|
| 47 |
Effects of Moringa oleifera Leaf Extract on the Liver of Experimentally-Induced Diabetic Wistar Rats. Folia Medica Indonesiana 2023; 59(2) doi: 10.20473/fmi.v59i2.37526
|
| 48 |
Ghada M. Khafagy, Hatem A. Darwish, Ayman Yosry, Naglaa A. Zayed, Ahmed M. Khairy, Eman I. Elmeshmeshy, Heba G. Elnahas. Non Alcoholic Fatty Liver Disease and Degree of Steatosis in Diabetic and Non- Diabetic patients. Obesity Medicine 2020; 19 doi: 10.1016/j.obmed.2020.100243
|
| 49 |
Juergen Sandow. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. 2020; doi: 10.1007/978-3-319-56637-5_33-1
|
| 50 |
Mohammad Ghasem Han, Masoud Cina, Mehrnoush Zakerkish, Fakher Rahim, Amal Saki-Maleh, Qasem Nissi. Correlation between Non-Alcoholic Fatty Liver Disease and Carotid Intima-Media Thickness in Patient with Type II Diabetes. International Journal of Osteoporosis and Metabolic Disorders 2015; 8(2) doi: 10.3923/ijom.2015.35.41
|
| 51 |
Emily J. Gallagher, Derek LeRoith, Marilyn Stasinopoulos, Zara Zelenko, Joseph Shiloach. Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes. Journal of Diabetes and its Complications 2016; 30(6) doi: 10.1016/j.jdiacomp.2016.04.019
|
| 52 |
Abbas Ali Sangouni, Shima Abdollahi, Hassan Mozaffari-Khosravi. Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial. BMC Cardiovascular Disorders 2022; 22(1) doi: 10.1186/s12872-022-02637-2
|
| 53 |
Alexandra Jichitu, Simona Bungau, Ana Maria Alexandra Stanescu, Cosmin Mihai Vesa, Mirela Marioara Toma, Cristiana Bustea, Stela Iurciuc, Marius Rus, Nicolae Bacalbasa, Camelia Cristina Diaconu. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. Diagnostics 2021; 11(4) doi: 10.3390/diagnostics11040689
|
| 54 |
Angezwa Siboto, Akinjide Moses Akinnuga, Muhammed Bilaal Ismail, Irvin Noel Booysen, Ntethelelo Hopewell Sibiya, Phikelelani Ngubane, Andile Khathi. Investigating the Protective Effects of a Rhenium (V) Compound with Uracil-Derived Ligands on Liver Damage Associated with Prediabetes in Diet-Induced Prediabetic Rats. Diabetology 2022; 3(4) doi: 10.3390/diabetology3040040
|
| 55 |
Benedetta M. Motta, Christoph Grander, Martin Gögele, Luisa Foco, Vladimir Vukovic, Roberto Melotti, Christian Fuchsberger, Alessandro De Grandi, Chiara Cantaloni, Anne Picard, Deborah Mascalzoni, Alessandra Rossini, Cristian Pattaro, Herbert Tilg, Peter P. Pramstaller. Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-02130-z
|
| 56 |
Dina Attia, Shereen Abdel Alem, Wafaa El‐Akel, Wael Abdel‐Razek, Mohamed Eslam, Yasser Fouad, Imam Waked. Prevalence and clinical characteristics of patients with metabolic dysfunction‐associated fatty liver disease with hepatitis C virus infection—a population‐based study. Alimentary Pharmacology & Therapeutics 2022; 56(11-12) doi: 10.1111/apt.17233
|
| 57 |
Satoshi Sato, Chikara Iino, Keisuke Furusawa, Kenta Yoshida, Daisuke Chinda, Kaori Sawada, Tatsuya Mikami, Shigeyuki Nakaji, Shinsaku Fukuda, Hirotake Sakuraba. Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population. Journal of Clinical Medicine 2025; 14(6) doi: 10.3390/jcm14062013
|
| 58 |
Wesal Elgretli, Mohamed Shengir, Solomon Sasson, Agnihotram V. Ramanakumar, Felice Cinque, Luz Esther Ramos Ballestreros, Marc Deschenes, Phil Wong, Tianyan Chen, Nadine Kronfli, Sahar Saeed, Alexa Keeshan, Saniya Tandon, Curtis Cooper, Giada Sebastiani. Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors. Journal of Viral Hepatitis 2025; 32(2) doi: 10.1111/jvh.70004
|
| 59 |
Naoya Otsubo, Tatsuya Fukuda, Genhin Cho, Fumiaki Ishibashi, Tetsuya Yamada, Koshiro Monzen. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People. Internal Medicine 2023; 62(16) doi: 10.2169/internalmedicine.1097-22
|
| 60 |
Miriam Rodriguez-Sosa, Tecilli Cabellos-Avelar, Yuriko Sanchez-Zamora, Imelda Juárez-Avelar, Esperanza García-Reyes, Alejandra Lira-León, José del Carmen Benítez-Flores, Thalia Pacheco-Fernández, Marcia Hiriart, Emma Berta Gutiérrez-Cirlos. Proinflammatory cytokine MIF plays a role in the pathogenesis of type-2 diabetes mellitus, but does not affect hepatic mitochondrial function. Cytokine 2017; 99 doi: 10.1016/j.cyto.2017.07.012
|
| 61 |
Claudia P. Oliveira, Priscila de Lima Sanches, Erlon Oliveira de Abreu-Silva, Aline Marcadenti. Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease. Journal of Diabetes Research 2016; 2016 doi: 10.1155/2016/4597246
|
| 62 |
Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6554
|
| 63 |
Satoshi Sato, Chikara Iino, Takafumi Sasada, Keisuke Furusawa, Kenta Yoshida, Kaori Sawada, Tatsuya Mikami, Shinsaku Fukuda, Shigeyuki Nakaji, Hirotake Sakuraba. A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population. Environmental Health and Preventive Medicine 2025; 30(0) doi: 10.1265/ehpm.24-00365
|
| 64 |
Younmi Kim, Heaji Lee, Sun Yeou Kim, Yunsook Lim. Effects of Lespedeza Bicolor Extract on Regulation of AMPK Associated Hepatic Lipid Metabolism in Type 2 Diabetic Mice. Antioxidants 2019; 8(12) doi: 10.3390/antiox8120599
|
| 65 |
Anca Trifan, Ermina Stratina, Robert Nastasa, Adrian Rotaru, Remus Stafie, Sebastian Zenovia, Laura Huiban, Catalin Sfarti, Camelia Cojocariu, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Carol Stanciu. Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter. Diagnostics 2022; 12(7) doi: 10.3390/diagnostics12071753
|
| 66 |
Nobuya Inagaki, Wayne H.-H. Sheu, David R. Owens, Susanne Crowe, Amit Bhandari, Yan Gong, Sanjay Patel. Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials. Journal of Diabetes and its Complications 2016; 30(8) doi: 10.1016/j.jdiacomp.2016.07.002
|
| 67 |
Rosa María Piña-Zentella, Jorge L. Rosado, Marco A. Gallegos-Corona, Luis Alberto Madrigal-Pérez, Olga P. García, Minerva Ramos-Gomez. Lycopene Improves Diet-Mediated Recuperation in Rat Model of Nonalcoholic Fatty Liver Disease. Journal of Medicinal Food 2016; 19(6) doi: 10.1089/jmf.2015.0123
|
| 68 |
Liang Wang. Ultrasound-Diagnosed Nonalcoholic Fatty Liver Disease Independently Predicts a Higher Risk of Developing Diabetes Mellitus in Nonoverweight Individuals. Academic Radiology 2019; 26(7) doi: 10.1016/j.acra.2018.08.019
|
| 69 |
Xia-Xia Zhao, Rui-Ling Wang, Ming-Hao Liu, Xiao-jun Huang, Chiara Ricci. Is the Occurrence or Reversal of Nonalcoholic Fatty Liver Disease Associated with Long-Term Helicobacter pylori Infection among Chinese Adults? A Cohort Study. Gastroenterology Research and Practice 2021; 2021 doi: 10.1155/2021/6696473
|
| 70 |
Jiaorong Tan, Jiahong Xu, Guohua Wei, Lijuan Zhang, Long’e Sun, Guangyu Wang, Fei Li, Fengxiang Jiang. HNF1α Controls Liver Lipid Metabolism and Insulin Resistance via Negatively Regulating the SOCS-3-STAT3 Signaling Pathway. Journal of Diabetes Research 2019; 2019 doi: 10.1155/2019/5483946
|
| 71 |
Edison Roberto PARISE. NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), MORE THAN A LIVER DISEASE. Arquivos de Gastroenterologia 2019; 56(3) doi: 10.1590/s0004-2803.201900000-45
|
| 72 |
Rui Wang, Yang Cheng, Jie Wang, Fengqian Liu, Jing Yu, Yun Wu. Development and Internal Validation of an Interpretable Machine Learning Screening Model for MAFLD–Diabetes Mellitus Comorbidity: A Cross-Sectional NHANES Study. Journal of Public Health and Preventive Medicine 2026; 2(9) doi: 10.64904/20260902
|
| 73 |
Natalie N. Atabaki, Daniel E. Coral, Hugo Pomares-Millan, Kieran Smith, Harry H. Behjat, Robert W. Koivula, Andrea Tura, Hamish Miller, Katherine E. Pinnick, Leandro Z. Agudelo, Kristine H. Allin, Andrew A. Brown, Elizaveta Chabanova, Piotr J. Chmura, Ulrik P. Jacobsen, Adem Y. Dawed, Petra J.M. Elders, Juan J. Fernandez-Tajes, Ian M. Forgie, Mark Haid, Tue H. Hansen, Angus G. Jones, Tarja Kokkola, Sebastian Kalamajski, Anubha Mahajan, Timothy J. McDonald, Donna McEvoy, Mirthe Muilwijk, Konstantinos D. Tsirigos, Jagadish Vangipurapu, Sabine van Oort, Henrik Vestergaard, Jerzy Adamski, Joline W. Beulens, Søren Brunak, Emmanouil T. Dermitzakis, Giuseppe N. Giordano, Ramneek Gupta, Torben Hansen, Leen M. ‘t Hart, Andrew T. Hattersley, Leanne Hodson, Markku Laakso, Ruth J.F. Loos, Jordi Merino, Mattias Ohlsson, Oluf Pedersen, Martin Ridderstråle, Hartmut Ruetten, Femke Rutters, Jochen M. Schwenk, Jeremy Tomlinson, Mark Walker, Hanieh Yaghootkar, Fredrik Karpe, Mark I. McCarthy, Elizabeth Louise Thomas, Jimmy D. Bell, Andrea Mari, Imre Pavo, Ewan R. Pearson, Ana Viñuela, Paul W. Franks. A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosis. Metabolism 2026; 178 doi: 10.1016/j.metabol.2026.156552
|
| 74 |
Sadaf Afraz, Nikhil Kapila. Endocrinology for the hepatologist. Clinical Liver Disease 2023; 22(1) doi: 10.1097/CLD.0000000000000037
|
| 75 |
Michaela Routhu, Vaclav Safka, Sunil Kumar Routhu, Tomas Fejfar, Vaclav Jirkovsky, Antonin Krajina, Eva Cermakova, Petr Hulek, Ladislav Hosak. Observational Cohort Study of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS). Annals of Hepatology 2017; 16(1) doi: 10.5604/16652681.1226932
|
| 76 |
. 2019; doi: 10.70675/aaef06b8z77e8z42ccz929cz1f7b59bd4414
|
| 77 |
Matthias Pinter, Florian Hucke, Nadine Zielonke, Michael Trauner, Wolfgang Sieghart, Markus Peck-Radosavljevic. Epidemiological Trends of Hepatocellular Carcinoma in Austria. Digestive Diseases 2014; 32(6) doi: 10.1159/000367983
|
| 78 |
Undurti N. Das. Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review. Journal of Advanced Research 2019; 17 doi: 10.1016/j.jare.2018.12.006
|
| 79 |
Yuchul Jeong, Beom Jun Lee, Wonjai Hur, Minjoon Lee, Se-Hyeon Han. Associations of Insulin Resistance and High-Sensitivity C-Reactive Protein with Metabolic Abnormalities in Korean Patients with Type 2 Diabetes Mellitus: A Preliminary Study. Metabolites 2024; 14(7) doi: 10.3390/metabo14070371
|
| 80 |
Yuko Tanimura, Wataru Aoi, Katsura Mizushima, Yasuki Higashimura, Yuji Naito. Combined treatment of dipeptidyl peptidase‐4 inhibitor and exercise training improves lipid profile in KK/Ta mice. Experimental Physiology 2019; 104(7) doi: 10.1113/EP087449
|
| 81 |
Elena-Daniela Grigorescu, Mariana Floria, Cristina Mihaela Lăcătușu, Bogdan Mircea-Mihai, Ioana Creţu, Alina Delia Popa, Alina Onofriescu, Irina M. Jaba, Victoriţa Șorodoc, Alexandr Ceasovschih, Laurenţiu Șorodoc. The Relationship between Hepatic Steatosis, inflammation and insulin Resistance in type 2 Diabetes with Metabolic Imbalance. Internal Medicine 2019; 16(4) doi: 10.2478/inmed-2019-0073
|
| 82 |
Xuetong Ni, Chao Tong, Aheyeerke Halengbieke, Tengrui Cao, Jianmin Tang, Lixin Tao, Deqiang Zheng, Yumei Han, Qiang Li, Xinghua Yang. Association between nonalcoholic fatty liver disease and type 2 diabetes: A bidirectional two-sample mendelian randomization study. Diabetes Research and Clinical Practice 2023; 206 doi: 10.1016/j.diabres.2023.110993
|
| 83 |
Anmol Mohan, Zim Warda Hasan, Hetvi Gordhan Galani, Tahniat Afroze, Rukash Khan Niazi, Razan Alfaki, Atika Shahzadi, Priyanka Mohan Lal, Hasibullah Aminpoor, Hasiba Karimi, Vikash Kumar, Usha Tejwaney, Sarwan Kumar. Diabetes and liver cirrhosis: shared pathways and clinical implications – a narrative review. Annals of Medicine & Surgery 2025; 87(12) doi: 10.1097/MS9.0000000000004012
|